Dissecting the role of microRNAs in prostate cancer metastasis

implications for the design of novel therapeutic approaches

Valentina Doldi, Marzia Pennati, Barbara Forte, Paolo Gandellini, Nadia Zaffaroni

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Metastatic prostate cancer is a lethal disease that remains incurable despite the recent approval of new drugs, thus making the development of alternative treatment approaches urgently needed. A more precise understanding of the molecular mechanisms underlying prostate cancer dissemination could lead to the identification of novel therapeutic targets for the design of efficient anti-metastatic strategies. MicroRNA (miRNAs) are endogenous, small non-coding RNA molecules acting as key regulators of gene expression at post-transcriptional level. It has been clearly established that altered miRNA expression is a common hallmark of cancer. In addition, emerging evidence suggests their direct involvement in the metastatic cascade. In this review, we present a comprehensive overview of the data generated in experimental tumor models indicating that specific miRNAs may impinge on the different stages of prostate cancer metastasis, including (i) the regulation of epithelial-to-mesenchymal transition and cell migration/invasion, (ii) the interplay between cancer cells and the surrounding stroma, (iii) the control of angiogenesis, (iv) the regulation of anoikis, and (v) the colonization of distant organs. Moreover, we show preliminary evidence of the clinical relevance of some of these miRNAs, in terms of association with tumor aggressiveness/dissemination and clinical outcome, as emerged from translation studies carried out in prostate cancer patient cohorts. We also discuss the potential and the current limitations of manipulating metastasis-related miRNAs, by mimicking or inhibiting them, as a strategy for the development of novel therapeutic approaches for the advanced disease.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalCellular and Molecular Life Sciences
DOIs
Publication statusAccepted/In press - Mar 12 2016

Fingerprint

MicroRNAs
Prostatic Neoplasms
Neoplasm Metastasis
Neoplasms
Anoikis
Therapeutics
Drug Approval
Small Untranslated RNA
Epithelial-Mesenchymal Transition
Regulator Genes
Cell Movement
Theoretical Models
Gene Expression

Keywords

  • Metastasis
  • MicroRNA
  • Prostate cancer
  • Therapeutic targets

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine
  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Dissecting the role of microRNAs in prostate cancer metastasis : implications for the design of novel therapeutic approaches. / Doldi, Valentina; Pennati, Marzia; Forte, Barbara; Gandellini, Paolo; Zaffaroni, Nadia.

In: Cellular and Molecular Life Sciences, 12.03.2016, p. 1-12.

Research output: Contribution to journalArticle

@article{85dffadf0b334c499f6ae60914b651de,
title = "Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches",
abstract = "Metastatic prostate cancer is a lethal disease that remains incurable despite the recent approval of new drugs, thus making the development of alternative treatment approaches urgently needed. A more precise understanding of the molecular mechanisms underlying prostate cancer dissemination could lead to the identification of novel therapeutic targets for the design of efficient anti-metastatic strategies. MicroRNA (miRNAs) are endogenous, small non-coding RNA molecules acting as key regulators of gene expression at post-transcriptional level. It has been clearly established that altered miRNA expression is a common hallmark of cancer. In addition, emerging evidence suggests their direct involvement in the metastatic cascade. In this review, we present a comprehensive overview of the data generated in experimental tumor models indicating that specific miRNAs may impinge on the different stages of prostate cancer metastasis, including (i) the regulation of epithelial-to-mesenchymal transition and cell migration/invasion, (ii) the interplay between cancer cells and the surrounding stroma, (iii) the control of angiogenesis, (iv) the regulation of anoikis, and (v) the colonization of distant organs. Moreover, we show preliminary evidence of the clinical relevance of some of these miRNAs, in terms of association with tumor aggressiveness/dissemination and clinical outcome, as emerged from translation studies carried out in prostate cancer patient cohorts. We also discuss the potential and the current limitations of manipulating metastasis-related miRNAs, by mimicking or inhibiting them, as a strategy for the development of novel therapeutic approaches for the advanced disease.",
keywords = "Metastasis, MicroRNA, Prostate cancer, Therapeutic targets",
author = "Valentina Doldi and Marzia Pennati and Barbara Forte and Paolo Gandellini and Nadia Zaffaroni",
year = "2016",
month = "3",
day = "12",
doi = "10.1007/s00018-016-2176-3",
language = "English",
pages = "1--12",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",

}

TY - JOUR

T1 - Dissecting the role of microRNAs in prostate cancer metastasis

T2 - implications for the design of novel therapeutic approaches

AU - Doldi, Valentina

AU - Pennati, Marzia

AU - Forte, Barbara

AU - Gandellini, Paolo

AU - Zaffaroni, Nadia

PY - 2016/3/12

Y1 - 2016/3/12

N2 - Metastatic prostate cancer is a lethal disease that remains incurable despite the recent approval of new drugs, thus making the development of alternative treatment approaches urgently needed. A more precise understanding of the molecular mechanisms underlying prostate cancer dissemination could lead to the identification of novel therapeutic targets for the design of efficient anti-metastatic strategies. MicroRNA (miRNAs) are endogenous, small non-coding RNA molecules acting as key regulators of gene expression at post-transcriptional level. It has been clearly established that altered miRNA expression is a common hallmark of cancer. In addition, emerging evidence suggests their direct involvement in the metastatic cascade. In this review, we present a comprehensive overview of the data generated in experimental tumor models indicating that specific miRNAs may impinge on the different stages of prostate cancer metastasis, including (i) the regulation of epithelial-to-mesenchymal transition and cell migration/invasion, (ii) the interplay between cancer cells and the surrounding stroma, (iii) the control of angiogenesis, (iv) the regulation of anoikis, and (v) the colonization of distant organs. Moreover, we show preliminary evidence of the clinical relevance of some of these miRNAs, in terms of association with tumor aggressiveness/dissemination and clinical outcome, as emerged from translation studies carried out in prostate cancer patient cohorts. We also discuss the potential and the current limitations of manipulating metastasis-related miRNAs, by mimicking or inhibiting them, as a strategy for the development of novel therapeutic approaches for the advanced disease.

AB - Metastatic prostate cancer is a lethal disease that remains incurable despite the recent approval of new drugs, thus making the development of alternative treatment approaches urgently needed. A more precise understanding of the molecular mechanisms underlying prostate cancer dissemination could lead to the identification of novel therapeutic targets for the design of efficient anti-metastatic strategies. MicroRNA (miRNAs) are endogenous, small non-coding RNA molecules acting as key regulators of gene expression at post-transcriptional level. It has been clearly established that altered miRNA expression is a common hallmark of cancer. In addition, emerging evidence suggests their direct involvement in the metastatic cascade. In this review, we present a comprehensive overview of the data generated in experimental tumor models indicating that specific miRNAs may impinge on the different stages of prostate cancer metastasis, including (i) the regulation of epithelial-to-mesenchymal transition and cell migration/invasion, (ii) the interplay between cancer cells and the surrounding stroma, (iii) the control of angiogenesis, (iv) the regulation of anoikis, and (v) the colonization of distant organs. Moreover, we show preliminary evidence of the clinical relevance of some of these miRNAs, in terms of association with tumor aggressiveness/dissemination and clinical outcome, as emerged from translation studies carried out in prostate cancer patient cohorts. We also discuss the potential and the current limitations of manipulating metastasis-related miRNAs, by mimicking or inhibiting them, as a strategy for the development of novel therapeutic approaches for the advanced disease.

KW - Metastasis

KW - MicroRNA

KW - Prostate cancer

KW - Therapeutic targets

UR - http://www.scopus.com/inward/record.url?scp=84960398557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960398557&partnerID=8YFLogxK

U2 - 10.1007/s00018-016-2176-3

DO - 10.1007/s00018-016-2176-3

M3 - Article

SP - 1

EP - 12

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

ER -